A Retro-Prospective, Non-randomized, Consecutive Series, SIngle Cohort, Multicenter Adaptive Design Study to Evaluate the Outcomes of Total Knee Arthroplasty (TKA) Using JOURNEY™ II BCS TotaL Knee SystEm (The NIMBLE Study)

Smith & Nephew, Inc.12 sites in 1 country209 target enrollmentJune 2012

ConditionsOsteoarthritis, Knee

Overview

Phase: N/A
Intervention: Not specified
Conditions: Osteoarthritis, Knee
Sponsor: Smith & Nephew, Inc.
Enrollment: 209
Locations: 12
Primary Endpoint: Rate of ITB Friction Pain
Status: Completed
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

Assess the safety and efficacy of the JOURNEY II BCS Total Knee System in subjects with degenerative knee disease requiring primary total knee replacement.

Detailed Description

Assess the safety and efficacy of the JOURNEY II BCS Total Knee System in subjects with degenerative knee disease requiring primary total knee replacement. Pre-operative and operative assessments collected retrospectively. All postoperative assessments beginning at the 6 month post-operative time point collected prospectively.

Registry

clinicaltrials.gov

Start Date

June 2012

End Date

July 31, 2023

Last Updated

last year

Study Type

Observational

Sex

All

Investigators

Sponsor

Smith & Nephew, Inc.

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Subject received primary total knee arthroplasty with the JOURNEY™ II BCS Total Knee System due to degenerative joint disease
•Subject is willing to sign and date an IRB approved consent form
•Subject is of legal age to consent
•Subject plans to be available through ten (10) years postoperative follow-up
•Subject agrees to follow the study protocol

Exclusion Criteria

•Subject received the JOURNEY™ II BCS Total Knee System on the affected knee as a revision for a previously failed total or unicondylar knee arthroplasty
•Subject received TKA on the contralateral knee as a revision for a previously failed total or unicondylar knee arthroplasty
•Subject possesses a contralateral or ipsilateral revision hip arthroplasty
•Subject has ipsilateral hip arthritis resulting in flexion contracture
•At the time of enrollment, subject has one or more of the following arthroplasties that are not fully healed and well-functioning, as determined by the investigator:
•Ipsilateral or contralateral primary total hip arthroplasty or hip resurfacing arthroplasty
•Contralateral primary total knee or unicondylar knee arthroplasty
•At the time of surgery, subject had an active infection or sepsis (treated or untreated)
•At the time of surgery, subject had presence of malignant tumor, metastatic, or neoplastic disease
•At the time of surgery, subject had conditions that may interfere with the TKA survival or outcome (i.e., Paget's or Charcot's disease, vascular insufficiency, muscular atrophy, uncontrolled diabetes, moderate to severe renal insufficiency or neuromuscular disease)

Outcomes

Primary Outcomes

Rate of ITB Friction Pain

Time Frame: 6 months post-operatively

Secondary Outcomes

Radiographic Evaluation(Baseline and 6 months post-operatively, 1 year post-operatively, 2 years post-operatively, 5 years post-operatively, and 10 years post-operatively)
Adverse Events(6 months post-operatively, 1 year post-operatively, 2 years post-operatively, 5 years post-operatively, and 10 years post-operatively)
Knee Society Score(6 months post-operatively, 1 year post-operatively, 2 years post-operatively, 5 years post-operatively, and 10 years post-operatively)